Showing results (291-300 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|July 19, 2022
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reportsMichael S Ewer, Jay HersonCardio-Oncology (London, England)|March 31, 2021
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case seriesRobert S Zhang, Allison Padegimas, Kathleen M Murphy, et al.Cardio-Oncology (London, England)|April 27, 2023
Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy - a prospective analysisMatthew Dean, Min Jung Kim, Sharon Dimauro, et al.Cardio-Oncology (London, England)|October 22, 2025
Radiation- and age-related vascular dysfunction as an early indicator of cardiovascular risk: a long-term study in the ApoE-/- mouse model of atherosclerosisBettina Habelt, Maximiliano Cuevas, Wolfgang DörrCardio-Oncology (London, England)|July 19, 2025
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsNaoki Watanabe, Tomoiku Takaku, Noriyoshi Iriyama, et al.Cardio-Oncology (London, England)|July 27, 2025
Explainable machine learning for neoplasms diagnosis via electrocardiograms: an externally validated studyJuan Miguel Lopez Alcaraz, Wilhelm Haverkamp, Nils StrodthoffCardio-Oncology (London, England)|July 3, 2025
Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapyJean Philippe Nesseler, Katrina D Silos, Olivia Peony, et al.Cardio-Oncology (London, England)|February 9, 2024
Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boostYvonne Koop, Femke Atsma, Marilot C T Batenburg, et al.Cardio-Oncology (London, England)|February 23, 2024
The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trialsAhmed Mazen Amin, Yehya Khlidj, Mohamed Abuelazm, et al.Cardio-Oncology (London, England)|March 16, 2024
Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunctionAzin Alizadehasl, Mina Mohseni, Kamran Roudini, et al.Pageof 45